NDLI: Neuroprotective strategies for HIV-1 associated dementia

Content Provider	Springer Nature Link
Author	DOU, Huanyu Kingsley, Jeffrey D. Mosley, R.Lee Gelbard, Harris A. Gendelman, Howard E.
Copyright Year	2004
Abstract	The human immunodeficiency virus-1 (HIV-1) commonly affects cognitive, behavioral and motor functions during the disease course. The neuropathogenesis of viral infection revolves around neurotoxins produced from infected and immune-activated mononuclear phagocytes (MP; perivascular macrophages and microglia). Direct infection of neurons occurs rarely, if at all. Neurologic disease arises in part as a consequence of MP metabolic dysfunction. Although the advent of highly active antiretroviral therapy (HAART) has attenuated the incidence and severity of neurologic disease, it, nonetheless, remains a common and disabling problem for those living with HIV-1 infection. Adjunctive therapies are currently designed to ameliorate clinical outcomes and are included in the therapeutic armamentarium. Antiinflammatory drugs that inhibit cytokines, chemokines and interferons linked to neurodegenerative processes can significantly ameliorate neuronal function. HIV-1 neurotoxins have the unique ability to up-regulate glycogen synthase kinase-3β (GSK-3β) activity that in turn elicits neuronal apoptosis. GSK-3β inhibitors are neuroprotective in animal models of Neuro AIDS. They are also currently in Phase 1 clinical trials designed for safety and tolerability in patients with HIV-1 infection. Neurotrophins are only beginning to be realized for their therapeutic potential in HIV-1 associated neurologic disease. This review article provides a broad overview of neuroprotective strategies for HIV-1 infection and details how such strategies act and may be implemented for treatment of human disease.
Starting Page	503
Ending Page	521
Page Count	19
File Format	PDF
ISSN	10298428
Journal	Neurotoxicity Research
Volume Number	6
Issue Number	7-8
e-ISSN	14763524
Language	English
Publisher	Springer-Verlag
Publisher Date	2004-01-01
Publisher Place	New York
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	HIV-1-associated dementia Neurotrophins Neurodegenerative diseases Neuroprotection Neuronal injury Monocyte-derived macrophages Neurosciences Pharmaceutical Sciences/Technology Neurology Neurochemistry Pharmacology/Toxicology Neurobiology
Content Type	Text
Resource Type	Article
Subject	Neuroscience Toxicology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

HIV-1 infected and immune competent mononuclear phagocytes induce quantitative alterations in neuronal dendritic arbor: Relevance for HIV-1-associated dementia

Adjunctive therapies for HIV-1 associated neurologic disease

Neuroprotective and neurorestorative strategies for neuronal injury

Human brain derived cell culture models of HIV-1 infection

The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia

Rodent model systems for studies of HIV-1 associated dementia

Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease

Neuroprotective strategies for HIV-1 associated dementia

Similar Documents

Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

HIV-1 infected and immune competent mononuclear phagocytes induce quantitative alterations in neuronal dendritic arbor: Relevance for HIV-1-associated dementia

Adjunctive therapies for HIV-1 associated neurologic disease

Neuroprotective and neurorestorative strategies for neuronal injury

Human brain derived cell culture models of HIV-1 infection

The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia

Rodent model systems for studies of HIV-1 associated dementia

Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease

Neuroprotective strategies for HIV-1 associated dementia